about
Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserineA case of invasive aspergillosis in CGD patient successfully treated with Amphotericin B and INF-gammaBinding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia.NADPH oxidases in lung health and diseaseThe multifarious, multireplicon Burkholderia cepacia complexInfluence of neutrophil defects on Burkholderia cepacia complex pathogenesis.Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leucocytes.Advances in electronic-nose technologies developed for biomedical applications.Inactivation of [Fe-S] metalloproteins mediates nitric oxide-dependent killing of Burkholderia mallei.Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.Fungal metabolite gliotoxin targets flavocytochrome b558 in the activation of the human neutrophil NADPH oxidaseNOX enzymes and pulmonary disease.Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting.Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus.Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidaseCopy number variations due to large genomic deletion in X-linked chronic granulomatous disease.PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease.Gastrointestinal and hepatic manifestations of primary immune deficiency diseases.McLeod syndrome: a neurohaematological disorder.Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacityChronic granulomatous disease: a review of the infectious and inflammatory complications.Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia.Inflammation and repeated infections in CGD: two sides of a coin.Mechanisms of resistance to oxidative and nitrosative stress: implications for fungal survival in mammalian hostsAtypical membrane-embedded phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2)-binding site on p47(phox) Phox homology (PX) domain revealed by NMR.A case of chronic granulomatous disease with a necrotic mass in the bronchus: a case report and a review of literature.Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.Case 2: Infant with lung nodules.Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution.Osteoarticular infectious complications in patients with primary immunodeficienciesAssociation between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patientsBurkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants.The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes.New frontiers in primary immunodeficiency disorders: immunology and beyond….Pulmonary manifestations of chronic granulomatous disease.ICON: the early diagnosis of congenital immunodeficiencies.Chronic granulomatous disease presenting as retinal mass.Long-term interferon-gamma therapy for patients with chronic granulomatous disease.The inducibility of TNF-alpha production is different in the granulocytic and monocytic differentiated forms of wild type and CGD-mutant PLB-985 cells.
P2860
Q23923115-AD614708-720C-4090-9E33-9EE414B18B44Q24803510-7B1197D4-1EBB-4D49-96E0-3217B5629EEBQ24807172-4C41C285-D757-4335-8FB2-5525F0027AB7Q27027435-47F898BA-CAEC-4BBC-B424-D7281A58F2BCQ28301994-83828D36-B820-478F-937D-F8E0F6AE0EB2Q30425441-F2DE0170-24EA-4059-9F4E-9B49A1D97469Q30437971-33E084BD-0D31-4001-8810-7B14EEA6F300Q30470504-25E17A42-181A-49D1-B471-C0FCA62A3FAEQ33327383-EE8C5A54-AD49-43C9-92BD-A8D8CBE43553Q33379412-49B9B5CD-370B-43B8-BABA-4D46B1465AC1Q33558138-D7F1A1C1-0ACE-4EAD-8F55-025A7F3EA365Q33649864-7BB626F0-503F-4571-8115-A81933D9ADA3Q33813874-D31D2AE1-68A3-4FD2-AEA3-ACC04947B2CCQ33821471-7647E8DE-47C5-4AA2-BDE7-A24C10638F57Q34146538-DCDA01AA-6DE1-42BC-92D2-2399DB1F55ACQ34181410-ABC5C5A0-DFF3-4EE2-81C0-12F9111B723AQ34374048-37F31556-18FF-4762-A8CD-23C7744A63E8Q34469023-14C38EB5-2571-42D1-9472-3A248AFF21D6Q34660441-11DCAF33-A618-4C45-A583-FE082F73D354Q35078505-6DADE473-A3A9-4B2B-96F0-F728C72E53D3Q35084276-F63CDD92-07D7-4EEC-BC16-48F04A7E0303Q35220405-C02B4F43-DB72-41B4-8BBD-3B986416A5C2Q35644145-50D6D2FD-1430-4F5F-AC19-326A63158749Q35859750-CE05FACB-5AD3-4CF5-9961-81D65E1E8071Q36006972-CD2D6838-4B11-4DFF-A157-88177833B6CBQ36495858-ADD4257C-9BD1-4CFF-B1E3-D09B9BCE9EB5Q36659242-87420F56-3729-4FB8-824E-94F32944B623Q36677933-3DA36E4D-BAF0-4413-BEDD-CBBFF686DBAFQ36860609-C12764D3-F1CC-4393-AFA3-6DF986F3330FQ37089046-AF3437A8-B5F3-43E6-AE6A-03733B213643Q37182510-BAA37A22-B376-432D-89DD-FABB2D7A31ADQ37202922-B568E2CA-7BA4-435A-97EE-5FB98C765D37Q37784697-5804773C-B068-40E3-9C77-FE68AA148958Q37825925-8EBE931D-9C41-42C3-90EF-9B5277B939A3Q37947135-694218A8-2D5B-440F-A2C9-D58B3D4F48FAQ38079835-B2BE0C90-98C4-413B-A402-85B92554B2E6Q38195246-8CCF7A81-00DF-451C-B89F-D008EADBBF82Q40406829-A7256A60-29C1-430A-B87B-5BB0AE71C7B5Q40526315-0996DE04-FE22-4527-BBD5-E7B30E616897Q40613667-32F27FC4-F064-47C2-A775-3434F9542A57
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Clinical aspects of chronic granulomatous disease.
@ast
Clinical aspects of chronic granulomatous disease.
@en
type
label
Clinical aspects of chronic granulomatous disease.
@ast
Clinical aspects of chronic granulomatous disease.
@en
prefLabel
Clinical aspects of chronic granulomatous disease.
@ast
Clinical aspects of chronic granulomatous disease.
@en
P1476
Clinical aspects of chronic granulomatous disease.
@en
P2093
Johnston RB Jr
P356
10.1097/00062752-200101000-00004
P577
2001-01-01T00:00:00Z